Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Return on Invested Capital: 2021

Historic Return on Invested Capital for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Dec 2021 value amounting to -0.81%.

  • Insight Molecular Diagnostics' Return on Invested Capital was N/A to -0.81% in Q4 2021 from the same period last year, while for Dec 2021 it was -0.81%, marking a year-over-year change of. This contributed to the annual value of -0.20% for FY2022, which is 66.00% up from last year.
  • As of Q4 2021, Insight Molecular Diagnostics' Return on Invested Capital stood at -0.81%, which was down 207.92% from -0.26% recorded in Q2 2021.
  • In the past 5 years, Insight Molecular Diagnostics' Return on Invested Capital ranged from a high of -0.26% in Q2 2021 and a low of -0.81% during Q4 2021.
  • In the last 1 years, Insight Molecular Diagnostics' Return on Invested Capital had a median value of -0.34% in 2021 and averaged -0.47%.